drugset / Trial / NCT03497273

Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

NCT03497273

Phase 1 Completed 14 enrolled Incyte Corporation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and tolerability of itacitinib in combination with corticosteroids in Japanese subjects with Grades II to IV acute graft-versus-host disease (aGVHD).

Timeline

Start
2018-03-20
Primary completion
2019-11-30
Completion
2020-02-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Itacitinib Small molecule Oral
Background Methylprednisolone Other / unclassified Intravenous
Background Prednisolone Other / unclassified Oral